# Ryplazim

NDC: 70573-099
Generic name: plasminogen
Labeler / Manufacturer: Kedrion Biopharma, Inc.
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210604

FDA application: BLA125659

## Active ingredients

- PLASMINOGEN: 68.8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70573-099"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70573-099